Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel H Maillard

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Revue Medicale Suisse|August 10, 2006
[Autoimmune pancreatitis: a new clinical entity]Michel H Maillard
Revue Medicale Suisse|March 9, 2007
[Resolvins: new derivates of fatty acids, polyunsaturated (omega-3) with therapeutic potential in inflammatory intestinal diseases]Michel H Maillard
Gastroenterology|August 8, 2007
Teaching tolerance with a probiotic antigen delivery systemMichel H Maillard, Scott B Snapper
Inflammatory Bowel Diseases|June 9, 2016
Preventing Overheating: Tight Control of Gut Innate Immunity in Health and DiseaseChristina Begka, Dominique Velin, Michel H Maillard
Revue Medicale Suisse|April 30, 2020
[Management of gastrointestinal and hepatic diseases during the COVID-19 outbreak]Sophie Restellini, Sophie Buyse, Sebastien Godat, et al.
Revue Medicale Suisse|July 5, 2017
[Diagnostic and treatment of mesenteric ischemia]Cristina Parliteanu, Mathilde Gavillet, Olivier Gié, et al.
Plos One|May 18, 2018
Patient-reported healthcare expectations in inflammatory bowel diseasesValérie Pittet, Carla Vaucher, Florian Froehlich, et al.
Revue Medicale Suisse|March 14, 2008
[Main therapeutic advances in IBD in 2007]Christian Felley, Christian Mottet, Michel H Maillard, et al.
Scandinavian Journal of Gastroenterology|February 20, 2016
Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?Carla Vaucher, Michel H Maillard, Florian Froehlich, et al.
Plos One|February 11, 2017
Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicatorValérie Pittet, Carla Vaucher, Florian Froehlich, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Revue Medicale Suisse|August 10, 2006
[Autoimmune pancreatitis: a new clinical entity]Michel H Maillard
Revue Medicale Suisse|March 9, 2007
[Resolvins: new derivates of fatty acids, polyunsaturated (omega-3) with therapeutic potential in inflammatory intestinal diseases]Michel H Maillard
Gastroenterology|August 8, 2007
Teaching tolerance with a probiotic antigen delivery systemMichel H Maillard, Scott B Snapper
Inflammatory Bowel Diseases|June 9, 2016
Preventing Overheating: Tight Control of Gut Innate Immunity in Health and DiseaseChristina Begka, Dominique Velin, Michel H Maillard
Revue Medicale Suisse|April 30, 2020
[Management of gastrointestinal and hepatic diseases during the COVID-19 outbreak]Sophie Restellini, Sophie Buyse, Sebastien Godat, et al.
Revue Medicale Suisse|July 5, 2017
[Diagnostic and treatment of mesenteric ischemia]Cristina Parliteanu, Mathilde Gavillet, Olivier Gié, et al.
Plos One|May 18, 2018
Patient-reported healthcare expectations in inflammatory bowel diseasesValérie Pittet, Carla Vaucher, Florian Froehlich, et al.
Revue Medicale Suisse|March 14, 2008
[Main therapeutic advances in IBD in 2007]Christian Felley, Christian Mottet, Michel H Maillard, et al.
Scandinavian Journal of Gastroenterology|February 20, 2016
Patients and gastroenterologists' perceptions of treatments for inflammatory bowel diseases: do their perspectives match?Carla Vaucher, Michel H Maillard, Florian Froehlich, et al.
Plos One|February 11, 2017
Patient self-reported concerns in inflammatory bowel diseases: A gender-specific subjective quality-of-life indicatorValérie Pittet, Carla Vaucher, Florian Froehlich, et al.
Pageof 4